State hands out R10bn ARV tenders

2014-12-24 12:09

Four pharmaceutical companies were jointly awarded a R10-billion tender to provide the health department with antiretroviral medication for three years.

“Various pharmaceutical companies won the three-year tender worth more than R10 billion to supply ARVs to millions of patients on treatment in South Africa for 2015 to 2017,” the department said today.

The tender was awarded as follows: Sonke Pharmaceuticals: R3 billion, Mylan Pharmaceuticals: R2.8 billion, Aspen Pharma: R2.5 billion and Cipla Medpro: R2 billion.

“There are more than 2.7 million people on ARV treatment in South Africa with about 1.5 million receiving the fixed-dose combination,” the department said.

“The health department aims to have about 4.6 million people on treatment by the end if 2016.”

In April last year, Health Minister Aaron Motsoaledi announced that the state was aiming to distribute the fixed dose combination.

Motsoaledi said at the time the simplified ARV medication would see people with HIV taking one tablet a day instead of three.

“We believe that the roll-out of the fixed-dose combination will assist a great deal in the management and treatment of HIV,” he said at the time.

“The fixed-dose combination will improve compliance and reduce the risk of patients not complying with treatment dosage.”

Motsoaledi said the “three drugs in one pill” was highly effective in reducing the viral load and would improve a patient’s immune response.

Newly diagnosed patients and HIV-positive pregnant women were put on fixed-dose combinations from the beginning of April 2013, while other “non-complicated” patients were switched to fixed-dose combinations on a permanent basis in June 2013.

Yesterday, Cipla Medpro chief executive Paul Miller said Cipla was proud to have been recognised as a preferred partner of the state in the national fight against HIV and Aids.

Miller said this was the third government tender win in the last year for Cipla Medpro.

It won a R280-million state therapeutic drug tender in August and a R345 million national respiratory tender in June.

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.